Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Gross Profit Margin (Quarterly): 89.71% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 89.71% |
| June 30, 2023 | 90.63% |
| Date | Value |
|---|---|
| March 31, 2023 | 88.60% |
| December 31, 2022 | 35.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
35.76%
Minimum
Dec 2022
90.63%
Maximum
Jun 2023
76.18%
Average
89.16%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -77.82% |
| Return on Assets | -64.99% |
| Return on Invested Capital | -77.82% |
| Profit Margin (Quarterly) | -987.2% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -483.2% |